Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study

BMJ 2013; 346 doi: (Published 8 January 2013)
Cite this as: BMJ 2013;346:e8525

Related articles

Letter: More evidence of nephrotoxicity with renin-angiotensin-aldosterone system blockers

Letter: The nephrotoxic “triple whammy” of combining diuretics, ACE inhibitors, and diuretics

Editorial: Safety of coprescribing NSAIDs with multiple antihypertensive agents

Data supplement

Web Extra

Web Extra

See more

Endgames: What is an “n-of-1” trial?

Editorial: Ruling out DVT using the Wells rule and a D-dimer test

Practice: How effective is tranexamic acid for acute gastrointestinal bleeding?

News: NICE keeps paracetamol in UK guidelines on osteoarthritis

This article has been cited by other articles: